Quality of Care for Medicaid-Enrolled Youth with Bipolar Disorders

Administration and Policy in Mental Health and Mental Health Services Research

Volumn 42, Issue 2, 2015, Pages 126-138

  Fontanella, Cynthia A ^a   Hiance Steelesmith, Danielle L ^a,b   Gilchrist, Richard ^a,c   Bridge, Jeffrey A ^b   Weston, Daniel ^a   Campo, John V ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Bipolar disorder; Children and adolescents; Quality of care; Treatment guidelines

Indexed keywords

TRANQUILIZER;

ADOLESCENT; BIPOLAR DISORDER; CHILD; DRUG MONITORING; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MEDICAID; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCEDURES; PROTOCOL COMPLIANCE; PSYCHOTHERAPY; UNITED STATES;

ADOLESCENT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAID; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84939884869     PISSN: 0894587X     EISSN: 15733289     Source Type: Journal    
DOI: 10.1007/s10488-014-0553-5     Document Type: Article

References (82)

1. American Academy of Child and Adolescent Psychiatry. (1997). Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry,36(1), 138–156.
2. Bauer, M. S. (2002). A review of quantitative studies of adherence to mental health practice guidelines. Harvard Review of Psychiatry,10, 138–153.
3. Bauer, M. S., McBride, L., Williford, W. O., Glick, H., Kinosian, B., Altshuler, L., … Sajatovic, M. (2006a). Collaborative care for bipolar disorder: Part I. Intervention and implementation in a randomized effectiveness trial. Psychiatric Services, 57, 927–936.
4. Bauer, M. S., McBride, L., Williford, W. O., Glick, H., Kinosian, B., Altshuler, L., … Sajatovic, M. (2006b). Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatric Services, 57, 937–945.
5. Bauer, M. S., Biswas, K., & Kilbourne, A. M. (2009). Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. American Journal of Psychiatry,166, 1244–1250.
6. Biederman, J., Faraone, S. V., Wozniak, J., Mick, E., Kwon, A., Cayton, G. A., et al. (2005). Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. Journal of Psychiatric Research,39, 611–622.
7. Blader, J. C., & Carlson, G. A. (2007). Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996–2004. Biological Psychiatry,62, 107–114.
8. Brown, E. S., Suppes, T., Adinoff, B., & Rajan Thomas, N. (2001). Drug abuse and bipolar disorder: Comorbidity or misdiagnosis? Journal of Affective Disorders,65, 105–115.
9. Buck, J. A. (2003). Medicaid, health care financing trends, and the future of state-base public mental health services. Psychiatric Services,54(7), 969–975.
10. Case, B. G., Olfson, M., Marcus, S. C., & Siegel, C. (2007). Trends in inpatient mental health treatment of children and adolescents in U.S. community hospitals between 1990 and 2000. Archives of General Psychiatry,64(1), 89–96.
11. Cohn, T., & Sernyak, M. (2006). Metabolic monitoring for patients treated with antipsychotic medications. Canadian Journal of Psychiatry,51(8), 492–501.
12. Correll, C. U., & Kratochvil, C. J. (2008). Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. Journal of the American Academy of Child and Adolescent Psychiatry,47(1), 9–20.
13. Correll, C. U., Sheridan, E. M., & DelBello, M. P. (2010). Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: A comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disorders,12(2), 116–141.
14. Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs,8(5), w770–w781.
15. Dennehy, E. B., Marangell, L. B., Allen, M. H., Chessick, C., Wisniewski, S. R., & Thase, M. E. (2011). Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Journal of Affective Disorders,133(3), 423–427.
16. Dickey, B., Normand, S. L., Norton, E. C., Rupp, A., & Azeni, H. (2002). Managed care and children’s behavioral health services in Massachusetts. Psychiatric Services,52, 183–188.
17. Dusetzina, S. B., Gaynes, B. N., Weinberger, M., Farley, J. F., Sleath, B., & Hansen, R. A. (2011). Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatric Services,62, 1443–1449.
18. Evans-Lacko, S. E., dosReis, S., Kastelic, E. A., Paula, C. S., & Stinwach, D. M. (2011). Evaluation of guideline concordant care for bipolar disorder among privately insured youth. Primary Care Companion to the Journal of Clinical Psychiatry,12(3), e1–e8.
19. Farmer, E. M. Z., Stangle, D. K., Burns, B. J., Costello, E. J., & Angold, A. (1999). Use, persistence, and intensity: Patterns of care for children’s mental health across one year. Community Mental Health Journal,35, 31–38.
20. Feeny, N. C., Danielson, C. K., Schwartz, L., Youngstrom, E. A., & Findling, R. L. (2006). Cognitive-behavioral therapy for bipolar disorders in adolescents: A pilot study. Bipolar Disorders,8(5), 508–515.
21. Ferrier, N., Pilling, S., & Bazire, S. (2006). Bipolar disorder: The management of bipolar disorder in adults, children, and adolescents in primary and secondary care. Leicester: The British Psychological Society.
22. Fontanella, C. A., Guada, J., Phillips, G., Ranbom, R., & Fortney, J. C. (2013). Individual and contextual-level factors associated with continuity of care for adults with schizophrenia. Administration and Policy in Mental Health. doi:10.1007/s10488-013-0500-x.
23. Fullerton, C. A., Epstein, A. M., Frank, R. G., Sharon-Lise, T. N., Fu, C. X., & McGuire, T. G. (2012). Medication use and spending trends among children with ADHD in Florida’s Medicaid Program, 1996–2005. Psychiatric Services,63, 115–121.
24. Garland, A. A., Hough, R. L., McCabe, K. M., Yeh, M., Wood, P. A., & Aaron, G. A. (2001). Prevalence of psychiatric disorders in youths across five sectors of care. Journal of the American Academy of Child and Adolescent Psychiatry,40(4), 409–418.
25. Goldman, H. H., Ganju, V., Drake, R. E., Gorman, P., Hogan, M., Hyde, P. S., et al. (2001). Policy implications for implementing evidence-based practices. Psychiatric Services,52, 1591–1597.
26. Goldstein, B. I., Strober, M. A., Birmaher, B., Axelson, D. A., Esposito-Smythers, C., Goldstein, T. R., … Keller, M. B. (2008). Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disorders, 10, 469–478.
27. Gore, F. M., Bloem, P. J., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., … Mathers, C. D. (2011). Global burden of disease in young people aged 10–24 years: A systematic analysis. Lancet, 377(9783), 2093–2102.
28. Harman, J. S., Childs, G. E., & Kelleher, K. J. (2000). Mental health care utilization and expenditures by children in foster care. Archives de Pediatrie,154, 1114–1117.
29. Haupt, D., & Newcomer, J. (2001). Hyperglycemia and antipsychotic medications. Journal of Clinical Psychiatry,62(s27), 15–26.
30. Hermann, R. C., & Palmer, R. H. (2002). Common ground: A framework for selecting core quality measures for mental health and substance abuse care. Psychiatric Services,53(3), 281–287.
31. Hosmer, D. W., Lemeshow, S., & Sturdivant, R. X. (2012). Applied logistic regression (3rd ed.). Hoboken, NJ: Wiley.
32. Johnson, G. (1998). Lithium-early development, toxicity, and renal function. Neuropsychopharmacology,19, 200–205.
33. Joshi, G., & Wilens, T. (2009). Comorbidity in pediatric bipolar disorder. Child and Adolescent Psychiatric Clinics of North America,18, 291–319.
34. Kessler, R. C., Avenevoli, S., & Ries Merikangas, K. (2001). Mood disorders in children and adolescents: An epidemiologic perspective. Biological Psychiatry,49, 1002–1014.
35. Kilbourne, A. M., Post, E. P., Bauer, M. S., Zeber, J. E., Copeland, L. A., Good, C. B., et al. (2007). Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. Journal of Affective Disorders,102(1), 145–151.
36. Kilbourne, A. M., Post, E. P., Nossek, A., Drill, L., Cooley, S., & Bauer, M. S. (2008). Improving medical and psychiatric outcomes among individuals with bipolar disorder: A randomized controlled trial. Psychiatric Services,59, 760–768.
37. Klees, B. S., Wolfe, C. J., & Curtis, C. A. (2010). Brief summaries of medicare & medicaid. Centers for Medicare and Medicaid Services. Accessed July 30, 2013 from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-reports/MedicareProgramRatesStats/downloads/MedicareMedicaidSummaries2010.pdf.
38. Kowatch, R. A., Fristad, M., Birmaher, B., Wagner, K. D., Findling, R. L., & Hellander, M. (2005). Child psychiatric workgroup on bipolar disorder. Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry,44(3), 213–236.
39. Kowatch, R. A., Strawn, J., & Sorter, M. (2009). Clinical trials support new algorithm for treating pediatric bipolar mania. Current Psychiatry,8(1), 19–34.
40. Kupfer, D. J. (2005). The increasing medical burden in bipolar disorder. JAMA,293(20), 2528–2530.
41. Leverich, G. S., Post, R. M., Keck, J. P., Altshuler, L. L., Frye, M. A., Kupka, R. W., … Luckenbaugh, D. (2007). The poor prognosis of childhood-onset bipolar disorder. Journal of Pediatrics, 150(5), 485–490.
42. Lurie, N., Popkin, M., Dysken, M., Moscovice, I., & Finch, M. (1992). Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital & Community Psychiatry,43(1), 69–71.
43. Marcus, S. C., Olfson, M., Pincus, H. A., Zarin, D. A., & Kupfer, D. J. (1999). Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. American Journal of Psychiatry,156(7), 1014–1018.
44. Martin, A., & Leslie, D. (2003). Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997–2000. American Journal of Psychiatry,160, 757–764. doi:10.1176/appi.ajp.160.4.757.
45. Matusui, D. (2007). Current issues in pediatric medication adherence. Pediatric Drugs,9, 283–288.
46. McClellan, J., Kowatch, R., & Findling, R. L. (2007). Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry,46(1), 107–125.
47. McGuire, T. G., & Miranda, J. (2008). New evidence regarding racial and ethnic disparities in mental health: Policy implications. Health Affairs,27(2), 393–403.
48. Mehler-Wex, C., Kölch, M., Kirchheiner, J., Antony, G., Fegert, J. M., & Gerlach, M. (2009). Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy. Child and Adolescent Psychiatry and Mental Health,3(1), 14. doi:10.1186/1753-2000-3-14.
49. Mitchell, P. B. (2000). Therapeutic drug monitoring of psychotropic medications. British Journal of Clinical Pharmacology,49, 303–312.
50. Moreno, C., Gonzalo, L., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry,64(9), 1032–1039.
51. Morrato, E. H., Nicol, G. E., Maahs, D., Druss, B. G., Hartung, D. M., Valuck, R. J., … Newcomer, J. W. (2010). Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatrics & Adolescent Medicine, 164(4), 344–351.
52. Ng, F., Mammen, O. K., Wilting, I., Sachs, G. S., Ferrier, I. N., Cassidy, F., … Berk, M. (2009). The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disorder, 11(6), 559–595.
53. Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry,167(12), 1456–1463.
54. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry,41(5), 514–521.
55. Olfson, M., Marcus, S. C., & Doshi, J. A. (2010). Continuity of care after inpatient discharge of patients with schizophrenia in the medicaid program: A retrospective longitudinal cohort analysis. Journal of Clinical Psychiatry,71(7), 831–838.
56. Pavuluri, M. N., Henry, D. B., Devineni, B., Carbray, J. A., Naylor, M. W., & Janicak, P. G. (2004). A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry,43(7), 859–867.
57. Pichini, S., Papaseit, E., Joya, X., Vall, O., Farre, M., Garcia-Algar, O., et al. (2009). Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics. Therapeutic Drug Monitoring,31(3), 283–318.
58. Reschovsky, J. D., & Staiti, A. B. (2005). Access and quality: Does rural America lag behind? Health Affairs,24(4), 1128–1139.
59. Sajatovic, M., Bauer, M. S., Kilbourne, A. M., Vertrees, J. E., & Williford, W. (2006). Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatric Services,57, 56–62.
60. Sala, R., Axelson, D., & Birmaher, B. (2009). Phenomenology, longitudinal course and outcome of children and adolescents with bipolar spectrum disorders. Child & Adolescent Psychiatric Clinics of North America,18(2), 273–289.
61. SAS Institute Inc. (2004). SAS Version 9.3. Cary, NC: SAS Institute Inc.
62. Satcher, D. (2001). Mental health: Culture, race, and ethnicity—a supplement to mental health: A report of the surgeon general. Washington, D.C.: U.S. Department of Health and Human Services.
63. Schöttle, D., Huber, C. G., Bock, T., & Meyer, T. D. (2011). Psychotherapy for bipolar disorder: A review of the most recent studies. Current Opinion in Psychiatry,24(6), 549–555.
64. Schraufnagel, T. J., Wagner, A. W., Miranda, J., & Roy-Byrne, P. P. (2006). Treating minority patients with depression and anxiety: What does the evidence tell us? General Hospital Psychiatry,28, 27–36.
65. Silber, J. H., Gleeson, S. P., & Zhao, H. (1999). The influence of chronic disease on resource utilization in common acute pediatric conditions: Financial concerns for children’s hospitals. Archives of Pediatrics and Adolescent Medicine,153, 169–179.
66. Simon, G. E., Ludman, E. J., Bauer, M. S., Unutzer, J., & Operskalski, B. (2006). Long-term effectiveness and cost of a systematic care program for bipolar disorder. Archives of General Psychiatry,63, 500–508.
67. Solomon, D. A., Keitner, G. I., Ryan, C. E., Kelley, J., & Miller, I. W. (2008). Preventing recurrence of bipolar I mood episodes and hospitalizations: Family psychotherapy plus pharmacotherapy versus pharmacotherapy alone. Bipolar Disorders,10(7), 798–805.
68. Sonne, S. C., Brady, K. Y., & Morton, W. A. (1994). Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease,182, 349–352.
69. STABLE (Standards for Bipolar Excellence). (2007). National Coordinating Council Resource Toolkit Workgroup. STABLE Resources Toolkit. Center for Quality Assessment and Improvement in Mental Health. Accessed July 30, 2013 from http://www.cqaimh.org/stable_toolkit.html.
70. Staples, B., & Bravender, T. (2002). Drug compliance in adolescents: Assessing and managing modifiable risk factors. Pediatric Drugs,4, 503–513.
71. Stevens, J., Wang, W., Fang, L., Edwards, M. C., Campo, J. V., & Gardner, W. (2009). Parental attitudes towards children’s use of antidepressants and psychotherapy. Journal of Child and Adolescent Psychopharmacology,19, 289–296.
72. Suppes, T., Dennehy, E., Hirschfeld, R., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., … Swann, A. C. (2005). The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. Journal of Clinical Psychiatry, 66, 870–886.
73. Taylor, V., & MacQueen, G. (2006). Association between bipolar disorder and metabolic syndrome: A review. Journal of Clinical Psychiatry,67(7), 1034–1041.
74. Unützer, J., Simon, G., Pabiniak, C., Bond, K., & Katon, W. (2000). The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO. General Hospital Psychiatry,22(1), 1–10.
75. Von Korff, M., Gruman, J., Schaefer, J., Curry, S. J., & Wagner, E. H. (1997). Collaborative management of chronic illness. Annals of Internal Medicine,127, 1097–1102.
76. Vornik, L. A., & Brown, E. S. (2006). Management of comorbid bipolar disorder and substance abuse. Journal of Clinical Psychiatry,67(suppl 7), 24–30.
77. Wagner, E. H., Austin, B. T., & Von Korff, M. (1996). Organizing care for patients with chronic illness. Milbank Quarterly,74, 511–544.
78. Woltmann, E., Grogan-Kaylor, A., Perron, B., Georges, H., Kilbourne, A. M., & Bauer, M. S. (2012). Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: Systematic review and meta-analysis. American Journal of Psychiatry,169, 790–804.
79. Wyatt, R. J., & Henter, I. (1995). An economic evaluation of manic-depressive illness-1991. Social Psychiatry and Psychiatric Epidemiology,30, 213–219.
80. Yatham, L. N., Kennedy, S. H., O’Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., … Gorman, C. P. (2005). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies. Bipolar Disorder, 7(s3), 5–69.
81. Zima, B. T., Hurlburt, M. S., Knapp, P., Ladd, H., Tang, L., Duan, N., … Wells, K. B. (2005). Quality of publically-funded outpatient speciality mental health care for common childhood psychiatric disorders in California. Journal of American Academy of Child and Adolescent Psychiatry, 44(2), 130–144.
82. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., … Riddle, M. A. (2003). Psychotropic practice patterns for youth: A 10 year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25.